SMT201300111B - Composizione a base di cellule epatiche incapsulate - Google Patents

Composizione a base di cellule epatiche incapsulate

Info

Publication number
SMT201300111B
SMT201300111B SM201300111T SM201300111T SMT201300111B SM T201300111 B SMT201300111 B SM T201300111B SM 201300111 T SM201300111 T SM 201300111T SM 201300111 T SM201300111 T SM 201300111T SM T201300111 B SMT201300111 B SM T201300111B
Authority
SM
San Marino
Prior art keywords
liver cells
composition based
encapsulated liver
encapsulated
erythropoietin
Prior art date
Application number
SM201300111T
Other languages
English (en)
Inventor
Krasimira Aleksanndrova
Peter Pediaditakis
Jo Salisbury
Wolfgang Rudinger
Original Assignee
Cytonet Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytonet Gmbh & Co Kg filed Critical Cytonet Gmbh & Co Kg
Publication of SMT201300111B publication Critical patent/SMT201300111B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SM201300111T 2009-04-27 2013-10-04 Composizione a base di cellule epatiche incapsulate SMT201300111B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/430,330 US20100272816A1 (en) 2009-04-27 2009-04-27 Microcapsules comprising liver cells and erythropoietin, methods for preparing said microcapsules and methods for treating a patient comprising applying said microcapsules to the patient
PCT/EP2010/002563 WO2010124837A2 (en) 2009-04-27 2010-04-27 Encapsulated liver cell composition

Publications (1)

Publication Number Publication Date
SMT201300111B true SMT201300111B (it) 2013-11-08

Family

ID=42790675

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201300111T SMT201300111B (it) 2009-04-27 2013-10-04 Composizione a base di cellule epatiche incapsulate

Country Status (26)

Country Link
US (3) US20100272816A1 (it)
EP (1) EP2424510B1 (it)
JP (1) JP5702771B2 (it)
KR (1) KR101372384B1 (it)
CN (2) CN102413820B (it)
AU (1) AU2010243888C1 (it)
BR (1) BRPI1014835A8 (it)
CL (1) CL2011002689A1 (it)
CY (1) CY1114464T1 (it)
DK (1) DK2424510T3 (it)
ES (1) ES2431297T3 (it)
HK (1) HK1165278A1 (it)
HR (1) HRP20130963T1 (it)
IL (1) IL215887A (it)
MX (1) MX2011010993A (it)
NZ (1) NZ595511A (it)
PL (1) PL2424510T3 (it)
PT (1) PT2424510E (it)
RS (1) RS52989B (it)
RU (2) RU2564924C2 (it)
SG (1) SG175792A1 (it)
SI (1) SI2424510T1 (it)
SM (1) SMT201300111B (it)
UA (1) UA99686C2 (it)
WO (1) WO2010124837A2 (it)
ZA (1) ZA201106817B (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI669843B (zh) * 2014-07-25 2019-08-21 日商積水化學工業股份有限公司 具備二次電池之發電裝置
WO2016183231A1 (en) 2015-05-12 2016-11-17 Baker Group, LLP Method and system for a bioartificial organ
RU2618989C1 (ru) * 2016-03-09 2017-05-11 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Способ лечения печеночной недостаточности
CN110129253A (zh) * 2016-09-14 2019-08-16 四川蓝光英诺生物科技股份有限公司 人工组织前体及制备其的方法
US11439731B2 (en) 2016-09-14 2022-09-13 Revotek Co., Ltd. Artificial tissue progenitor and method for preparing the same
WO2018093069A1 (ko) * 2016-11-15 2018-05-24 광주과학기술원 세포 3d 배양 방법
EP3943129A4 (en) * 2019-03-20 2022-12-14 Public University Corporation Yokohama City University COATING PROTECTION AGENT

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5455790A (en) 1977-10-05 1979-05-04 Tomoyuki Tajima Production of erythropoetin
JPS6045849B2 (ja) 1980-08-25 1985-10-12 林原 健 ヒトエリトロポエチンの製造方法
NZ210501A (en) 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
US4956128A (en) * 1984-05-25 1990-09-11 Connaught Laboratories Limited Droplet generation
IL77081A (en) 1984-12-04 1999-10-28 Genetics Inst AND sequence encoding human erythropoietin, a process for its preparation and a pharmacological preparation of human erythropoietin
US5084350A (en) * 1990-02-16 1992-01-28 The Royal Institution For The Advance Of Learning (Mcgill University) Method for encapsulating biologically active material including cells
WO1994025055A1 (en) 1993-04-29 1994-11-10 Abbott Laboratories Erythropoietin analog compositions and methods
IL110669A (en) 1993-08-17 2008-11-26 Kirin Amgen Inc Erythropoietin analogs
RU94030310A (ru) * 1994-08-16 1996-08-10 Молдавский научно-исследовательский институт профилактической и клинической медицины МЗ Республики Молдова (MD) Способ культивирования клеток человека и животных
US6281015B1 (en) * 1994-12-16 2001-08-28 Children's Medical Center Corp. Localized delivery of factors enhancing survival of transplanted cells
PL375067A1 (en) 2002-07-19 2005-11-14 Vesta Therapeutics, Inc. Method of obtaining viable human liver cells, including hepatic stem/progenitor cells
CA2550301A1 (en) * 2003-12-30 2005-07-14 Bionethos Holding Gmbh Tissue regeneration method
CA2561725A1 (en) * 2004-03-30 2005-10-13 Fac8Cell Pty Limited Culture and use of cells that secrete liver secretory factors
US20090214660A1 (en) * 2005-10-21 2009-08-27 Living Cell Products Pty Limited Encapsulation system

Also Published As

Publication number Publication date
US20140017305A1 (en) 2014-01-16
UA99686C2 (ru) 2012-09-10
KR20120014171A (ko) 2012-02-16
HK1165278A1 (en) 2012-10-05
CN103638002B (zh) 2016-05-18
JP5702771B2 (ja) 2015-04-15
KR101372384B1 (ko) 2014-03-12
WO2010124837A2 (en) 2010-11-04
CL2011002689A1 (es) 2012-04-27
US8535923B2 (en) 2013-09-17
RS52989B (en) 2014-02-28
JP2012524739A (ja) 2012-10-18
CN102413820B (zh) 2013-09-25
MX2011010993A (es) 2011-11-02
US20100272816A1 (en) 2010-10-28
US20120093937A1 (en) 2012-04-19
ZA201106817B (en) 2012-11-28
CN103638002A (zh) 2014-03-19
PT2424510E (pt) 2013-10-14
BRPI1014835A2 (pt) 2016-04-12
EP2424510B1 (en) 2013-07-17
HRP20130963T1 (hr) 2013-11-22
EP2424510A2 (en) 2012-03-07
RU2564924C2 (ru) 2015-10-10
AU2010243888C1 (en) 2014-01-23
DK2424510T3 (da) 2013-10-07
CN102413820A (zh) 2012-04-11
RU2013143436A (ru) 2015-03-27
NZ595511A (en) 2013-02-22
IL215887A (en) 2016-05-31
BRPI1014835A8 (pt) 2018-02-14
SG175792A1 (en) 2011-12-29
SI2424510T1 (sl) 2013-11-29
ES2431297T3 (es) 2013-11-25
AU2010243888A1 (en) 2011-10-27
RU2011148106A (ru) 2013-06-10
CY1114464T1 (el) 2016-10-05
PL2424510T3 (pl) 2013-12-31
WO2010124837A3 (en) 2011-02-10
AU2010243888B2 (en) 2013-08-22
US9517247B2 (en) 2016-12-13
IL215887A0 (en) 2012-01-31
RU2500390C2 (ru) 2013-12-10

Similar Documents

Publication Publication Date Title
SMT201300111B (it) Composizione a base di cellule epatiche incapsulate
SG11201400942YA (en) Memory cells and memory cell arrays
BR112012014158A2 (pt) "célula eletroquímica"
DK2048955T3 (da) Målrettet gen-tilførsel til dendrit-cellevaccination
DK3354665T5 (da) Modificerede alginater til celleindkapsling og celleterapi
EP2896066A4 (en) METHOD FOR PRODUCING MEMORY CELLS AND ARRAYS FROM MAGNETIC MEMORY CELL STRUCTURES AND ASSOCIATED MEMORY CELLS AND MEMORY CELL STRUCTURES
FR2993101B1 (fr) Procede d'assemblage et d'encapsulation de microbatteries au lithium et microbatteries ainsi obtenue
FR2957186B1 (fr) Cellule memoire de type sram
BR112012008436A2 (pt) eletrodo catódico, célula eletroquimica e seus usos
EP2901455A4 (en) MEMORY CELL WITH PARTITIONED GATE WITH SUBSTRATE STRESSORREGION AND MANUFACTURING METHOD THEREFOR
DK3205351T3 (da) Enzym til lysosomale lagringssygdomme
HK1213911A1 (zh) 和/或 易感細胞、細胞系和非人動物的開發
ZA201202364B (en) Dye sensitised solar cell
SG11201406117PA (en) Encapsulating material for solar cell and solar cell module
DK2817070T3 (da) Kosmetiske sammensætninger indeholdende multebær-cellekultur-præparat
FR2994618B1 (fr) Cellule d'accumulateur photovoltaique
FR2950709B1 (fr) Systeme electrochrome transparent a plusieurs paires d'electrodes d'alimentation
EP2630659A4 (en) INTEGRATED CIRCUIT ARRANGEMENT COMPRISING NONVOLATILE MEMORY CELLS AND METHODS OF FORMING NONVOLATILE MEMORY CELL
EP2635305A4 (en) IMPROVEMENT OF PATHOGENIC TH17 MEMORY LANGUAGES
FR2989222B1 (fr) Materiau d'encapsulation de cellules photovoltaiques
IT1396868B1 (it) Struttura di connessione per connettere esternamente celle di batteria.
MY153067A (en) Encapsulated liver cell composition
HK1169885A1 (en) Dye sensitised solar cell and method of manufacture
ITVI20120169A1 (it) Applicazione dell'incapsulante a backsheet per moduli fotovoltaici utilizzanti celle contattate posteriormente
TH124821B (th) องค์ประกอบเซลล์ตับที่ถูกห่อหุ้ม (Encapsulated Liver Cell Composition)